Role of herbal medicines to treat the symptoms of COVID-19 disease
Journal Title: TMR Clinical Research - Year 2021, Vol 4, Issue 2
Abstract
The need for effective therapeutic options for patients has received increasing attention in response to the prevalence of COVID 19. Although there are several options for the prevent of COVID-19, including vaccines, monoclonal antibodies, oligonucleotide-based therapies, peptides, and interferon therapies, no treatment for coronaviruses has yet been approved.
Authors and Affiliations
Mohammad Ali Zakeri1, Mahlagha Dehghan2*
Keywords
Related Articles
- EP ID EP695492
- DOI 10.12032/TMRCR20210522009
- Views 98
- Downloads 0
Explore the mechanism and treatment analysis of Acupuncture and Moxibustion for Constipation after Stroke
Modern research has shown that there is a special brain-gut axis between the brain and the gut, which can regulate and maintain the stable function of the body. Many studies have also proved that acupuncture at certain a...
Clinical observation of Shengxuebao Mixture in treating anemia after concurrent chemoradiotherapy for cervical cancer
Objective: To investigate the efficacy of the Shengxuebao Mixture in treating anemia after concurrent chemoradiotherapy for cervical cancer. Methods: The patients who met the criteria were randomly divided into the study...
Visual analysis of advance care planning related studies
Backgroud: To provide a reference for the further development of the field of the advance care planning (ACP), through the visual analysis of the related literature on the ACP. Methods: Taking the core collection databas...
Construction of an intelligent patient satisfaction assessment system and its application in emergency management
Hospital emergency management work is of great importance which not only related to the life and health of the people but also related to social stability. It is necessary to construct and improve the patient satisfacti...
Insight into the post-hospital syndrome
After hospitalization, the patient faces a brief fragile period of susceptibility to disease and a high incidence of adverse events (re-admission or death, etc.), which is described by cardiologist Harlan M.Krumholz as p...